India News
-
Abuse of clinical trial laws need to be prevented
India | Opinion | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2012
Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, proper dosage range and side effects, prior to the drug being certified a...Read more
-
QIAGEN gets SFDA's nod for careHPV Test
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagn...Read more
-
GlobalData: Osteoporosis market to be $8 bn
India | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more
-
Cipla gets drug pricing breather from Delhi Court
India | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more
-
Industry body expresses concern over Nexavar decision
India | News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012
The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology industry in India, reacted sharply to India's grant of a compulsory li...Read more
-
APAC ovarian cancer drug market to grow modestly'
India | Analysis | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2015
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more
-
Hyderabad to host BioAsia from Jan 28
India | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2012
Bangalore: The 10th edition of much anticipated annual biotechnology and life sciences platform BioAsia will be held in Hyderabad, India, from January 28 to 30, 2013. The event will be held...Read more
-
Indian Government strengthens clinical trials regulations
India | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Bangalore: In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian Government has announced several measures to strengthen the regulation and moni...Read more
-
BMS pledges $15 million to help curb diabetes in India and China
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: The Bristol-Myers Squibb Foundation has expanded its Together on Diabetes initiative to China and India, pledging $15 million over five years to help these developing nations wit...Read more
-
Dishman Pharma records 13.2% growth
India | Company results | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Bangalore: Dishman Pharma has posted a 13.24 percent growth in the fourth quarter of FY12 and reported a consolidated net profit of Rs 312.94 million for the quarter ended 31 March, 2012, u...Read more
-
Dr. Reddy's revenues cross $2 billion milestone
India | Company results | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Hyderabad: Dr. Reddy's Laboratories announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards...Read more
-
Genetic diagnostics companies speed ahead
India | Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more
-
US FDA approves Suprax 400 mg by Lupin
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US Food and Drugs Administration (FDA). A statement re...Read more
-
Bristol-Myers Squibb reveals new grants for Hepatitis in India, China
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, July 30, 2012: The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatiti...Read more
-
Another Wockhardt plant banned by the US FDA
India | News | By BioSpectrum Bureau | 0 Comment | 02 Dec, 2013
Mumbai: New product launch approvals of Wockhardt are going to be delayed as a second plant operated by the generic drug maker was hit by the US FDA import alert. This ban results in detent...Read more
-
India | News | By BioSpectrum Bureau | 0 Comment | 19 Mar, 2012
"When I look at Dr Reddy what inspires me most is the sheer passion with which he dreams, he looks at R&D or the passion of creating an institution, the passion for philanthropy. It is ...Read more
-
HCL provides hospital information systems to Narayana Hrudalaya
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Bangalore: HCL Infosystems, India's premier hardware, services and ICT systems integration and distribution company has been chosen as a strategic technology partner by Narayana Hrudayalaya...Read more
